These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 8280772

  • 21. Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells.
    Whatley RE, Clay KL, Chilton FH, Triggiani M, Zimmerman GA, McIntyre TM, Prescott SM.
    Prostaglandins; 1992 Jan; 43(1):21-9. PubMed ID: 1546171
    [Abstract] [Full Text] [Related]

  • 22. A comparative study of the effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet activating factor on histamine and leukotriene C4 release from human leukocytes.
    Columbo M, Horowitz EM, Patella V, Kagey-Sobotka A, Chilton FH, Lichtenstein LM.
    J Allergy Clin Immunol; 1993 Aug; 92(2):325-33. PubMed ID: 7688778
    [Abstract] [Full Text] [Related]

  • 23. Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells.
    Hichami A, Duroudier V, Leblais V, Vernhet L, Le Goffic F, Ninio E, Legrand A.
    Eur J Biochem; 1997 Dec 01; 250(2):242-8. PubMed ID: 9428670
    [Abstract] [Full Text] [Related]

  • 24. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
    Bauldry SA, Wooten RE.
    Biochim Biophys Acta; 1996 Sep 06; 1303(1):63-73. PubMed ID: 8816854
    [Abstract] [Full Text] [Related]

  • 25. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
    Kulikov VI, Muzya GI.
    Biochemistry (Mosc); 2000 Apr 06; 65(4):427-30. PubMed ID: 10810178
    [Abstract] [Full Text] [Related]

  • 26. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets].
    Muzia GI, Kulikov VI.
    Biokhimiia; 1996 Mar 06; 61(3):455-60. PubMed ID: 8724603
    [Abstract] [Full Text] [Related]

  • 27. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs].
    Orlov SM, Kulikov VI, Pol'ner AA, Bergel'son LD.
    Biokhimiia; 1985 Apr 06; 50(4):680-5. PubMed ID: 2408682
    [Abstract] [Full Text] [Related]

  • 28. Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo.
    Kulikov VI, Muzya GI.
    Biochemistry (Mosc); 2002 Nov 06; 67(11):1248-52. PubMed ID: 12495421
    [Abstract] [Full Text] [Related]

  • 29. Development of a novel scintillation proximity radioimmunoassay for platelet-activating factor measurement: comparison with bioassay and GC/MS techniques.
    Sugatani J, Lee DY, Hughes KT, Saito K.
    Life Sci; 1990 Nov 06; 46(20):1443-50. PubMed ID: 2111868
    [Abstract] [Full Text] [Related]

  • 30. Identification of a lysophospholipase C that may be responsible for the biosynthesis of choline plasmalogens by Madin-Darby canine kidney cells.
    Strum JC, Daniel LW.
    J Biol Chem; 1993 Dec 05; 268(34):25500-8. PubMed ID: 8244986
    [Abstract] [Full Text] [Related]

  • 31. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
    Yamazaki Y, Yasuda K, Matsuyama T, Ishihara T, Higa R, Sawairi T, Yamaguchi M, Egi M, Akai S, Miyase T, Ikari A, Miwa M, Sugatani J.
    Biochem Pharmacol; 2013 Sep 01; 86(5):632-44. PubMed ID: 23817078
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Stimulated neutrophils produce an ethanolamine plasmalogen analog of platelet-activating factor.
    Tessner TG, Wykle RL.
    J Biol Chem; 1987 Sep 15; 262(26):12660-4. PubMed ID: 3114260
    [Abstract] [Full Text] [Related]

  • 35. Antibodies to synthetic platelet-activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) analogues with substituents at the sn-2 position.
    Karasawa K, Satoh N, Masuda M, Setaka M, Hashimoto K, Ishibashi K, Nojima S.
    J Biochem; 1991 Nov 15; 110(5):683-7. PubMed ID: 1723729
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [The effect of aldehydogenic and acyl structural analogs of platelet activating factor on the formation of superoxide radicals by human blood leukocytes].
    Kuznetsova TI, Kulikov VI.
    Biokhimiia; 1992 Jan 15; 57(1):16-20. PubMed ID: 1327185
    [Abstract] [Full Text] [Related]

  • 38. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    J Lipid Mediat; 1990 Jan 15; 2(1):21-31. PubMed ID: 1966804
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.